Vimarsana
Biggest News Aggregation in the World

Page 12 - Genentech News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Genentech. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Genentech Today - Breaking & Trending Today

Why women's health has become a priority for brands - Vimarsana News

Why women's health has become a priority for brands

Check out how marketers can best reach women and discuss their health needs in a post-pandemic world.

Confidential Information Provided to Genentech Leaked in Third-Party Lash Group Data Breach | Console and Associates, P.C. - Vimarsana News

Confidential Information Provided to Genentech Leaked in Third-Party Lash Group Data Breach | Console and Associates, P.C.

On May 20, 2024, Lash Group filed a notice of data breach with the multiple state attorney general offices disclosing a data breach affecting information provided to the Lash Group by...

The winners of the 2024 PRWeek Healthcare Awards - Vimarsana News

The winners of the 2024 PRWeek Healthcare Awards

The winners of the 2024 PRWeek Healthcare Awards. From PR Week

Source: prweek.com
Roche granted FDA Breakthrough Device Designation for blood test measuring Lp(a) – a key marker for hereditary cardiovascular risk - Vimarsana News

Roche granted FDA Breakthrough Device Designation for blood test measuring Lp(a) – a key marker for hereditary cardiovascular risk

Approximately one in five people worldwide have elevated Lp levels, putting them at increased risk of cardiovascular diseases including myocardial infarction and stroke.1The Roche Diagnostics...

F. Hoffmann-La Roche Ltd: Roche granted FDA Breakthrough Device Designation for blood test measuring Lp(a) - a key marker for hereditary cardiovascular risk - Vimarsana News

F. Hoffmann-La Roche Ltd: Roche granted FDA Breakthrough Device Designation for blood test measuring Lp(a) - a key marker for hereditary cardiovascular risk

Approximately one in five people worldwide have elevated Lp(a) levels, putting them at increased risk of cardiovascular diseases including myocardial infarction and stroke.1The Roche Diagnostics Tina-quant®